| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |